Arrhythmia Disorders News

PHILADELPHIA — In a phase 2b trial, abelacimab, a novel factor XI inhibitor, drastically reduced bleeding compared with rivaroxaban in patients with atrial fibrillation requiring stroke prevention.

PHILADELPHIA — In patients with subclinical atrial fibrillation, apixaban lowered risk for stroke but increased risk for bleeding compared with aspirin, according to the results of the ARTESIA trial.

The Healio team is providing live coverage of the American Heart Association's Scientific Sessions in Philadelphia.

Healio and Cardiology Today have compiled a list of the most-read cardiology news of October 2023.

Much has been written about the potential of artificial intelligence-aided remote interventions to help cardiologists improve patient care, but potential drawbacks and practical issues all must be considered.

SAN FRANCISCO — Left atrial appendage occlusion at the time of transcatheter aortic valve replacement provides a noninferior treatment option to TAVR plus medical therapy in patients with severe aortic stenosis and atrial fibrillation.

Medtronic announced it received FDA approval for its extravascular implantable cardioverter-defibrillator and defibrillation lead to treat tachycardia that may cause sudden cardiac arrest.

Recently, there have been a number of cases in which high-profile athletes have had sudden cardiac arrest due to a variety of causes.

With nearly 90% accuracy, an artificial intelligence-based model consistently predicted atrial fibrillation within 31 days among patients with sinus rhythm, according to findings published in JAMA Cardiology.

InfoBionic announced it received FDA 510(k) clearance for its next-generation remote ECG monitoring device with a Bluetooth diagnostic six-lead sensor for patients who require cardiac monitoring.